Summary
The recognition that asthma constitutes 2 kinds of physiopathological reactions, namely bron-chospasms (immediate reactions) and inflammatory responses (late reactions), suggests that the treatment should be focused against these events. Furthermore, the allergen provocation model, showing the existence of immediate and late asthmatic reactions, can be used to study the effects of different antiasthmatic drugs. Recently, the importance of inflammation in the pathogenesis of asthma in adults has led to the development of therapeutic regimens in which anti-inflammatory treatments are used frequently as a first-line step in the management of asthma. Although at the moment the hard data showing inflammation in childhood asthma are scarce, it is assumed that childhood asthma constitutes the same kind of chronic inflammatory processes as in adult asthma and that its treatment should also include anti-inflammatory drugs.
Similar content being viewed by others
References
Aalberse R, Kauffman HF, Groen H, Koëter GH, de Monchy JGR. The effect of nedocromil sodium on the early and late reaction and allergen-induced bronchial hyperresponsiveness. Journal of Allergy and Clinical Immunology 87: 993–1001, 1991
Adachi M, Kobajashi H, Aoki N, Lijima M, Fokubu F, Furuja A, Takahashi T. Comparison of the inhibitory effect of keto-tifen and disodium cromoglycate on bronchial responses to house dust, with special reference to the late asthmatic reaction. Pharmatherapeutica 4: 36–42, 1984
Baker AJ, Fuller RW. Anti-inflammatory effect of salmeterol on human alveolar macrophages. American Review of Respiratory Disease 141: A394, 1990
Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. American Review of Respiratory Disease 139: 806–817, 1989
Bel EH, Timmers MC, Dijkman JH, Stahl EG, Sterk PJ. The effect of an inhaled leukotriene antagonist, L-648, 051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man. Journal of Allergy and Clinical Immunology 85: 1067–1075, 1990
Berlow BA, Liebhaber MI, Dyer Z, Spiegel TM. The effect of dapsone in steroid-dependent asthma. Journal of Allergy and Clinical Immunology 87: 710–715, 1991
Bernstein DI, Bernstein IL, Bodenheimer SS, Pietrusko RG. An open study of auranofin in the treatment of steroid-dependent asthma. Journal of Allergy and Clinical Immunology 81: 6–16, 1988
Bianco S, Pieroni MG, Refini RM, et al. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reasons. New England Journal of Medicine 321: 1069–1073, 1989
Bierman CW. A comparison of late reactions to antigen and exercise. Journal of Allergy and Clinical Immunology 73: 654–659, 1984
Booij-Noord H, De Vries K, Sluiter HJ, Orie NGM. Late bronchial obstructive reaction to experimental inhalation of house dust extract. Clinical Allergy 2: 43–61, 1972
Booij-Noord H, Orie NGM, De Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. Journal of Allergy and Clinical Immunology 48: 344–354, 1971
Boulet LP, Cartier A, Thomson NC, Roberts RS, Dolovich J, et al. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. Journal of Allergy and Clinical Immunology 71: 399–406, 1983
Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. Journal of Allergy and Clinical Immunology 86: 292–305, 1990
British Thoracic Society. Research Unit of the Royal College of Physicians of London, King’s Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults. I. Chronic persistent asthma. British Medical Journal 301: 651–653, 1990
Britton JR, Burney PG, Chinn S, Papacosta AO, Tattersfield AE. The relation between change in airway reactivity and change in respiratory symptoms and medication in a community survey. American Review of Respiratory Disease 138: 530–534, 1988
Burge PS, Efthimou J, Turner-Warwick M, Nelmes PTJ. Double-blind trials of inhaled beclomethasone dipropionate and fluo-cortin butyl ester in allergen-induced immediate and late asthmatic reactions. Clinical Allergy 12: 523–531, 1982
Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-1986. British Medical Journal 300: 1306–1310, 1990
Cartier A, Thomson NC, Frith PA, Roberts R, Hargreave FE. Allergen-induced increase in bronchial responsiveness to hista-mine: relationship to the late asthmatic response and change in airway caliber. Journal of Allergy and Clinical Immunology 70: 170–177, 1982
Casale TB. Neuropeptides and the lung. Journal of Allergy and Clinical Immunology 88: 1–14, 1991
Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. Journal of Allergy and Clinical Immunology 83: 905–912, 1989
Chazan R, Walajtys-Rode E, Grubek-Jaworska H, Madalinska M, Droszcz W. In vitro and in vivo effect of salbutamol on histamine release from human basophils. International Journal of Clinical Pharmacology Therapy and Toxicology 29: 9–13, 1991
Church MK, Hiroi J. Inhibition of IgE dependent histamine release from human dispersed mast cells by anti-allergic drugs and salbutamol. British Journal of Pharmacology 90: 421–429, 1987
Cockcroft DW. Mechanism of perennial allergic asthma. Lancet 1: 253–256, 1983
Cockcroft DW. Therapy for airway inflammation in asthma. Journal of Allergy and Clinical Immunology 87: 914–919, 1991
Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. Journal of Allergy and Clinical Immunology 79: 734–740, 1987
Cockcroft DW, Murdock KY, Gore BP, O’Byrne PM, Manning P. Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine. Journal of Allergy and Clinical Immunology 83: 913–920, 1990
Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clinical Allergy 7: 503–513, 1977
Crimi E, Brusasco V, Crimi P. Effect of nedocromil sodium on the late asthmatic reaction to bronchial allergen challenge. Journal of Allergy and Clinical Immunology 83: 985–990, 1989
De Baets F, Goeteyn M, Kerrebijn KF. The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house dust mite antigen in asthmatic children. American Review of Respiratory Disease 142: 581–586, 1990
De Cleyn KM, Kersschot EA, De Clerck LG, Ortmanns PM, De Schepper AM, et al. Paranasal sinus pathology in allergic and non-allergic respiratory tract disease. Allergy 41: 313–319, 1986
De Monchy JGR, Kauffman HF, Venge P, Koëter GH, Jansen HM, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. American Review of Respiratory Disease 131: 373–376, 1985
Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Roche WR, et al. The effect of inhaled beclomethasone dipropionate (BDP) on inflammatory cells in the asthmatic airways. Abstract 135. Journal of Allergy and Clinical Immunology 87: 172, 1991
Erzurum SC, Leff JA, Evans Cochran J, Ackerson LM, Szefler SJ, et al. Lack of benefit of methotrexate in severe, steroid-dependent asthma. Annals of Internal Medicine 114: 353–360, 1991
Fairfax AJ, Hanson JM, Morley J. The late reaction following bronchial provocation with house dust mite allergen: dependence on arachidonic acid metabolism. Clinical and Experimental Immunology 52: 393–398, 1983
Ferguson AC, Wong FWM. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosi-nophils in broncholavage fluid. Chest 96: 988–991, 1989
Flotte TR, Loughlin GM. Benefits and complications of trolean-domycin (TAO) in young children with steroid-dependent asthma. Pediatric Pulmonology 10: 178–182, 1991
Gergen PJ, Mullally DI, Evans R. National survey of prevalence of asthma among children in the United States, 1976 to 1980. Pediatrics 81: 1–7, 1988
Gerrard JW, MacKenzie JWA, Goluboff N, Garson JZ, Maningas CS. Cow’s milk allergy: prevalence and manifestations in an unselected series of newborns. Acta Paediatrica Scandinavica (Suppl.) 234: 1–21, 1973
Ghosh SK, De Vos C, Mcllroy I, Patel KR. Effect of cetirizine on histamine- and leukotriene D4-induced bronchocon-striction in patients with atopic asthma. Journal of Allergy and Clinical Immunology 87: 1010–1013, 1991
Hamid M, Rafferty P, Holgate ST. The inhibitory effect of ter-fenadine and flurbiprofen on early and late-phase broncho-constriction following allergen challenge in atopic asthma. Clinical and Experimental Allergy 20: 261–267, 1990
Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. Journal of Allergy and Clinical Immunology 85: 1098–1111, 1990
Hay IFC, Higgenbottam TW. Has the management of asthma improvéd? Lancet 2: 609–611, 1987
Heino M, Juntunen-Backman K, Leijala M, Rapola J, Laitinen LA. Bronchial epithelial inflammation in children with chronic cough after early lower respiratory tract illness. American Review of Respiratory Disease 141: 428–432, 1990
Holgate ST. Clinical evaluation of nedocromil sodium in asthma. European Journal of Respiratory Diseases 69(Suppl. 147): 149–159, 1986
Kay AB. Asthma and inflammation. Journal of Allergy and Clinical Immunology 87: 893–910, 1991
Keating G, Mitchell EA, Jackson R, Beaglehole R, Rea H. Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. British Medical Journal 289: 348–351, 1984
Kerrebijn KF. Endogenous factors in childhood CNSLD. In Orie NGM, van der Lende R (Eds) Bronchitis III, pp. 38–48, van Gorcum, Assen, 1970
Kerrebijn KF. Triggers of airway inflammation. European Journal of Respiratory Diseases 69(Suppl. 147): 98–104, 1986
Kerrebijn KF. Use of topical corticosteroids in the treatment of childhood asthma. American Review of Respiratory Disease 141: S77–S81, 1990
Kerrebijn KF. Ketotifen for long-term control of asthma in children. Journal of Allergy and Clinical Immunology 86: 274–275, 1990
Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effects of longterm treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. Journal of Allergy and Clinical Immunology 79: 653–659, 1987
Kirby JG, Hargreave FE, Cockcroft DW, O’Byrne PM. Effect of indomethacin on allergen-induced asthmatic responses. Journal of Applied Physiology 66: 578–583, 1989
König P, Godfrey S. The effect of frequent administration of sodium cromoglycate to asthmatic children who previously responded poorly. Clinical Allergy 3: 395–402, 1973
Kraan J, Koeter GH, van der Mark ThW et al. Changes in bronchial hyperreactivity induced by 4 weeks treatment with anti-asthma drugs in patients with allergic asthma: a comparison of budesonide and terbutaline. Journal of Allergy and Clinical Immunology 76: 628–636, 1985
Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. American Review of Respiratory Disease 131: 599–606, 1985
Lau S, Falkenhorst G, Weber A, Werthmann I, Lind P, et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. Journal of Allergy and Clinical Immunology 84: 718–725, 1989
Levinson AI, Wheatley LM. Intravenous immunoglobulin: a new therapeutic approach in steroid-dependent asthma? Journal of Allergy and Clinical Immunology 88: 552–554, 1991
Loftus BG, Price JF. Clinical and immunological characteristics of pre-school asthma. Clinical Allergy 16: 152–257, 1986
Mailing H-J. Immunotherapy position paper. Allergy 43(Suppl. 6): 7–33, 1988
Mattoli S, Foresi A, Corbo GM, Valente S, Ciappi G. Effects of two doses of cromolyn on allergen-induced late asthmatic response and increased responsiveness. Journal of Allergy and Clinical Immunology 79: 747–754, 1987
Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. Journal of Allergy and Clinical Immunology 87: 976–983, 1991
Mitchell EA, Dawson KP. Why are admissions of children with acute asthma increasing? European Respiratory Journal 2: 470–472, 1989
Mullarkey MF, Blumenstein BA, Andrade WP, Baily GA, Olason I, et al. Methotrexate in the treatment of corticosteroid-de-pendent asthma: a double-blind study. New England Journal of Medicine 318: 603–607, 1988
O’Byrne PM, Hargreave FE, Kirby JG. Airway inflammation and hyperresponsiveness. American Review of Respiratory Disease 136: S35–S37, 1987
Pauwels R, Van Renterghem D, Van Der Straeten M, Johannesson N, Persson CGA. The effect of theophylline and enpro-fylline on allergen-induced bronchoconstriction. Journal of Allergy and Clinical Immunology76: 583–590, 1985
Pepys J, Davies RJ, Breslin ABX, Hendrick DJ, Hutchcroft BJ. The effects of inhaled beclomethasone dipropionate (Becotide) and sodium cromoglycate on asthmatic reactions to provocation tests. Clinical Allergy 4: 13–24, 1974
Platts-Mills TA, Mitchell EB, Nock P, Tovey ER, Moszor H, et al. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 2: 675–678, 1982
Price JF, Hey EN, Soothill JF. Antigen provocation to the skin, nose and lung, in children with asthma: immediate and dual hypersensitivity reactions. Clinical and Experimental Immunology 47: 587–594, 1982
Rafferty P, Phillips G, Clough J, et al. The inhibitory actions of azelastine hydrochlorine on the early and late bronchocon-strictor responses to inhaled allergen in atopic asthma. Journal of Allergy and Clinical Immunology 84: 649–657, 1989
Raihi LM, Charpin D, Thibaudon M, Vervloet D. Bronchial challenge to house dust can induce immediate bronchoconstriction in allergic asthmatic patients. Annals of Allergy 65: 485–488, 1990
Reid MJ, Moss RB, Hsu Y-P, Kwasnicki JM, Commerford TM, et al. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. Journal of Allergy and Clinical Immunology 78: 590–600, 1986
Russell G, Jones SP. Selection of skin tests in childhood asthma. British Journal of Diseases of the Chest 70: 104–106, 1976
Schuster A, Kozlik R, Reinhardt D. Influence of short- and long-term inhalation of salbutamol on lung function and beta2-adrenoceptors of mononuclear blood cells in asthmatic children. European Journal of Pediatrics 150: 209–213, 1991
Sears MR. Increasing asthma mortality — fact or artifact? Editorial. Journal of Allergy and Clinical Immunology 82: 957–960, 1988
Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391–1396, 1990
Simpson H. Viral infection in asthma. Progression in Respiratory Research 19: 181–188, 1985
Tabachnik E, Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. Journal of Pediatrics 118: 294–297, 1991
Taylor IK, O’Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337: 690–694, 1991
Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST. Protection against allergen-induced asthma by salmeterol. Lancet 336: 1338–1342, 1990
Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reaction and increase in airway responsiveness provoked by inhaled allergen in asthma. American Review of Respiratory Disease 144: 782–787, 1991
Twentyman OP, Holgate ST. Effect of the H1-receptor antagonist and novel anti-allergic agent azelastine on the allergen-induced late phase asthmatic response. American Review of Respiratory Disease 141: A838, 1990
van Schayck CP, Visch MB, van Herwaarden CLA, Dorpeling E, Van Wed C. Increased bronchial hyperresponsiveness after inhaling salbutamol during one year is not caused by desensi-tisation to salbutamol. Journal of Allergy and Clinical Immunology 86: 793–800, 1990
Van Bever HP, Desager KN, Stevens WJ. The effect of fenoterol, administered during the late asthmatic reaction to house dust mite (Dermatophagoides pteronyssinus). Journal of Allergy and Clinical Immunology 85: 700–703, 1990
Van Bever HP, Stevens WJ. Late asthmatic reactions in childhood asthma. In Vermeire P et al. (Eds) Progress in asthma and COPD, pp. 35–48, Excerpta Medica, Amsterdam, 1989a
Van Bever HP, Stevens WJ. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clinical and Experimental Allergy 19: 399–404, 1989b
Vathenen AS, Knox AJ, Higgins BG, et al. Rebound increase in bronchial responsiveness after treatment with inhaled terbu-taline. Lancet 1: 554–558, 1988
Wales JKH, Barnes ND, Switft PFG. Growth retardation in children on steroids for asthma. Lancet 338: 1535, 1991
Warner JO. The significance of late reactions following bronchial challenge with house dust mite. Archives of Disease in Childhood 51: 905–911, 1976
Warner JO. Mites and asthma in children. British Journal of Diseases of the Chest 72: 79–87, 1978
Warner JO, Götz M, Landau LI, Levison H, Milner AD, et al. Management of asthma: a consensus statement. Archives of Disease in Childhood 64: 1065–1079, 1989
Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate-day pred-nisone on pituitary-adrenal function in children with chronic asthma. New England Journal of Medicine 299: 1387–1392, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Bever, H.P., Stevens, W.J. Pharmacotherapy of Childhood Asthma. Drugs 44, 36–46 (1992). https://doi.org/10.2165/00003495-199244010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199244010-00003